C4 glomerulopathy epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Tarek Nafee (talk | contribs) (Created page with "__NOTOC__ {{C4 glomerulopathy}} {{CMG}}; {{APM}}; {{AE}} {{OO}} ==Overview== ==Epidemiology and Demographics== ===Prevalence=== ===Incidence=== ===Age=== ===Gender=== ===Ra...") |
Norina Usman (talk | contribs) (→Age) |
||
Line 10: | Line 10: | ||
===Incidence=== | ===Incidence=== | ||
===Age=== | ===Age=== | ||
Patients of all age groups may develop C4 glomerulopathy. | |||
===Gender=== | ===Gender=== | ||
===Race=== | ===Race=== |
Revision as of 23:18, 2 August 2020
C4 glomerulopathy Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
C4 glomerulopathy epidemiology and demographics On the Web |
American Roentgen Ray Society Images of C4 glomerulopathy epidemiology and demographics |
Risk calculators and risk factors for C4 glomerulopathy epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Ali Poyan Mehr, M.D. [2]; Associate Editor(s)-in-Chief: Olufunmilola Olubukola M.D.[3]
Overview
Epidemiology and Demographics
Prevalence
Incidence
Age
Patients of all age groups may develop C4 glomerulopathy.